The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,311,894 in first-year total cost, median $2,155,947.
Most frequent study sections
- Special Emphasis Panel[ZMH1 ERB-L (02)]2
Most frequent institutions
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
- UNIVERSITY OF CALIFORNIA RIVERSIDE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Targeting the NLRP3 Inflammasome to Mitigate Neuroinflammation and HIV Persistence in the CNS: Mechanisms and Therapeutic Strategies1RF1MH141600-01 | AKBARIAN, SCHAHRAMCHEN, BENJAMIN KSWARTZ, TALIA H | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $3,613,504 | ZMH1 |
| 2025 | Harnessing Innate Immunity to Control the Neuroinflammatory HIV Reservoir1R01NS148274-01 | KAUL, MARCUSPEDERSEN, IRENE MUNK | UNIVERSITY OF CALIFORNIA RIVERSIDE, CA | $698,390 | ZMH1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.